Physician profile
Dennis A Conrad
NPI 1427165406
$16,863.82
in general payments reported to CMS, 2019-2025
6 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what a typical Pediatric Infectious Diseases provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,785 · 2020: $3,027 · 2021: $475 · 2022: $3,235 · 2023: $1,769 · 2024: $1,212 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,341.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10,998.95 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $5,743.72 | 2019 | |
| Biomerieux INC | $40.00 | 2023 | Biofire Respiratory Panel 2.1 |
| Biofire Diagnostics, LLC | $40.00 | 2021 | |
| Photocure INC | $23.88 | 2019 | |
| Karl Storz Endoscopy-America | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.